BCPC · Balchem Corp
$178.51
+1.37 (+0.77%)
At close · Aug 14
Market Cap
$5.69B
Shares
31.88M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.04B
+8.8%
FY2025
Net Income
$154.85M
+20.5%
FY2025
Gross Margin
35.74%
+0.5pp
FY2025
Operating Margin
20.18%
+1pp
FY2025
Diluted EPS
$4.75
+20.9%
FY2025
Operating Cash Flow
$216.56M
+19%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.09B | $1.04B | $953.68M | $922.44M | $942.36M | $799.02M | $703.64M | $643.71M | $643.68M | $594.79M | $553.2M | $552.49M | $541.38M | $337.17M | $310.39M | $291.87M | $255.07M | $219.44M | |
| -$22.45M | — | — | -$22.61M | -$10.27M | -$2.46M | -$4.44M | -$5.96M | -$7.61M | -$7.53M | -$7.26M | — | — | — | — | — | — | — | |
| $691.76M | $666.53M | $617.48M | $620.38M | $661.91M | $555.85M | $479.75M | $432.34M | $439.43M | $405.78M | $372.34M | $384.4M | $397.21M | $239.75M | $220.85M | $205.87M | $177.03M | $152.48M | |
| $394.12M | $370.63M | $336.21M | $302.06M | $280.45M | $243.17M | $223.9M | $211.37M | $204.25M | $189.01M | $180.86M | $168.1M | $144.17M | $97.42M | $89.54M | $86M | $78.04M | $66.96M | |
| — | 35.74% | 35.25% | 32.75% | 29.76% | 30.43% | 31.82% | 32.84% | 31.73% | 31.78% | 32.69% | 30.43% | 26.63% | 28.89% | 28.85% | 29.47% | 30.59% | 30.51% | |
| $19.96M | $18.51M | $16.79M | $15.05M | $12.19M | $13.52M | $10.33M | $11.38M | $11.59M | $9.31M | $7.33M | $5.99M | $4.81M | $3.62M | $3.42M | $2.89M | $3.19M | $3.3M | |
| $71.06M | $67.42M | $67.59M | $53.42M | $55.67M | $41.74M | $43.79M | $36.51M | $28.34M | $28.08M | $27.53M | $21.9M | $21.46M | $12.28M | $10.41M | $10.6M | $9.47M | $8.65M | |
| — | — | — | — | — | — | — | — | — | — | — | $2.9M | $2.9M | — | — | — | — | — | |
| $17.37M | $16.99M | $19.24M | $28.04M | $27.27M | $25.09M | $27.81M | $25.79M | $24.99M | $26.78M | $29.77M | $26.47M | $19.47M | $3.98M | $3.97M | $3.97M | $3.92M | — | |
| $47.98M | $45.69M | $47.97M | $54.94M | $51.85M | $48.88M | $51.28M | $45.86M | $44.67M | $44.38M | $46.2M | $39.96M | $30.52M | $10.47M | $9.64M | $9.29M | $8.56M | $8.13M | |
| $172.4M | $161.31M | $153.3M | $142.86M | $135.27M | $115.67M | $112.75M | $108.81M | $97.15M | $92.11M | $90.02M | $74.14M | $62.03M | $31.82M | $29.76M | $29.78M | $28.27M | $26.3M | |
| $221.72M | $209.33M | $182.91M | $159.19M | $145.19M | $127.5M | $111.15M | $102.55M | $107.1M | $96.9M | $90.84M | $93.96M | $82.14M | $65.6M | $59.78M | $56.23M | $49.77M | $40.66M | |
| — | 20.18% | 19.18% | 17.26% | 15.41% | 15.96% | 15.8% | 15.93% | 16.64% | 16.29% | 16.42% | 17.01% | 15.17% | 19.46% | 19.26% | 19.26% | 19.51% | 18.53% | |
| $269.7M | $255.02M | $230.88M | $214.13M | $197.03M | $176.38M | $162.43M | $148.42M | $151.77M | $141.28M | $137.04M | $133.92M | $112.67M | $76.08M | $69.42M | $65.52M | $58.33M | $48.79M | |
| $7.79M | — | — | — | — | — | — | — | — | $7.54M | $7.27M | $6.59M | $5.15M | $24K | $10K | $84K | $90K | $209K | |
| $15K | — | — | — | — | — | — | — | — | $12K | $9000 | $9000 | $64K | $277K | $10K | $184K | $289K | $107K | |
| -$9.33M | -$10.3M | -$16.46M | -$21.93M | -$11.44M | -$2.27M | -$4.73M | -$6.08M | -$8.07M | -$8.42M | -$7.9M | -$6.89M | -$5.09M | $216K | $67K | $513K | $361K | -$57K | |
| $212.38M | $199.03M | $166.45M | $137.26M | $133.75M | $125.23M | $106.42M | $96.48M | $99.03M | $88.49M | $82.93M | $87.06M | $77.05M | $65.82M | $59.84M | $56.74M | $50.13M | $40.6M | |
| $47.97M | $44.19M | $37.98M | $28.72M | $28.38M | $29.13M | $21.79M | $16.81M | $20.46M | -$1.58M | $26.96M | $27.34M | $24.23M | $20.94M | $19.84M | $17.97M | $16.85M | $13.82M | |
| $164.41M | $154.85M | $128.48M | $108.54M | $105.37M | $96.1M | $84.62M | $79.67M | $78.57M | $90.07M | $55.97M | $59.72M | $52.83M | $44.87M | $40.01M | $38.77M | $33.28M | $26.79M | |
| — | 14.93% | 13.47% | 11.77% | 11.18% | 12.03% | 12.03% | 12.38% | 12.21% | 15.14% | 10.12% | 10.81% | 9.76% | 13.31% | 12.89% | 13.28% | 13.05% | 12.21% | |
| $78.01M | — | — | — | — | — | — | — | $78.57M | $90.07M | $55.97M | $59.72M | $52.83M | $44.87M | $40.01M | $38.77M | $33.28M | $26.79M | |
| $150.11M | $220.14M | $96.04M | $124.39M | $103.21M | $86.94M | $94.36M | $77.71M | $76.61M | $95.28M | $54.24M | $57.26M | $49.98M | $45.83M | $40.18M | $38.38M | $32.58M | $26.95M | |
| USD/shares | — | $4.80 | $3.97 | $3.38 | $3.29 | $2.98 | $2.63 | $2.48 | $2.45 | $2.83 | $1.78 | $1.92 | $1.74 | $1.51 | $1.38 | $1.36 | $1.19 | $0.98 |
| USD/shares | — | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 | $2.60 | $2.45 | $2.42 | $2.79 | $1.75 | $1.89 | $1.69 | $1.45 | $1.32 | $1.28 | $1.12 | $0.93 |
| shares | — | 32.27M | 32.33M | 32.11M | 32.02M | 32.22M | 32.18M | 32.14M | 32.09M | 31.84M | 31.52M | 31.16M | 30.38M | 29.62M | 28.99M | 28.57M | 27.96M | 27.42M |
| shares | — | 32.6M | 32.72M | 32.45M | 32.39M | 32.67M | 32.5M | 32.51M | 32.45M | 32.23M | 31.92M | 31.64M | 31.17M | 30.85M | 30.35M | 30.24M | 29.62M | 28.87M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $235.06M in buybacks, $222.45M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.93×
EV/EBIT
—
Peer median 26.24×
P/E (TTM)
35.07×
Peer median 24.87×
Peer medians compare against the 33 similar-size Specialty Chemicals companies (of 66 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Human Nutrition and Health | $659,387,000 | $600,258,000 | $550,751,000 | $527,131,000 | $442,733,000 | $400,330,000 | $347,433,000 | $341,237,000 |
| Animal Nutrition and Health | $230,852,000 | $214,710,000 | $238,326,000 | $262,297,000 | $226,776,000 | $192,191,000 | $177,557,000 | $175,693,000 |
| Specialty Products | $140,976,000 | $132,749,000 | $125,965,000 | $131,438,000 | $117,020,000 | $103,566,000 | $92,257,000 | $75,808,000 |
| Industrial Products | — | — | — | — | — | — | $26,458,000 | $50,941,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $759,448,000 | $723,300,000 | $689,601,000 | $682,238,000 | $584,661,000 | $516,347,000 | $475,033,000 | $482,691,000 |
| Non Us | $277,713,000 | $230,384,000 | $232,838,000 | $260,120,000 | $214,362,000 | $187,297,000 | $168,672,000 | $160,988,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Product Sales | $1,035,272,000 | $951,947,000 | $919,951,000 | $939,166,000 | $794,518,000 | $666,193,000 | $609,741,000 | $607,879,000 |
| Royalty | $1,889,000 | $1,737,000 | $2,488,000 | $3,192,000 | $4,505,000 | $4,291,000 | $4,360,000 | $4,487,000 |
| Bill and Hold | — | — | — | — | — | $1,158,000 | — | $4,612,000 |
| Co-Manufacturing | — | — | — | — | — | $29,063,000 | $24,087,000 | $24,259,000 |
| Consignment | — | — | — | — | — | — | $2,299,000 | — |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Human Nutrition and Health | $153,906,000 | $135,957,000 | $102,419,000 | $82,125,000 | $76,031,000 | $61,397,000 | $48,429,000 |
| Specialty Products | $42,901,000 | $39,906,000 | $34,579,000 | $32,789,000 | $30,020,000 | $26,801,000 | $28,513,000 |
| Animal Nutrition and Health | $18,687,000 | $14,013,000 | $27,576,000 | $36,056,000 | $26,179,000 | $29,979,000 | $25,868,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Human Nutrition and Health | 23.3% | 22.6% | 18.6% | 15.6% | 17.2% | 15.3% | 13.9% |
| Animal Nutrition and Health | 8.1% | 6.5% | 11.6% | 13.7% | 11.5% | 15.6% | 14.6% |
| Specialty Products | 30.4% | 30.1% | 27.5% | 24.9% | 25.7% | 25.9% | 30.9% |
Key facts
CIK
9326
CUSIP
057665200
13F (30d)
387 filings
382 filers
Visit website
Investor relations